Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31

Jennifer Permuth‐Wey; Kate Lawrenson; Howard C. Shen; Aneliya Velkova; Jonathan P. Tyrer; Zhihua Chen; Hui‐Yi Lin; Y. Ann Chen; Ya-Yu Tsai; Xiaotao Qu; Susan J. Ramus; Rod Karevan; Janet Lee; Nathan Lee; Melissa C. Larson; Katja K.H. Aben; Hoda Anton‐Culver; Natalia Antonenkova; Antonis C. Antoniou; Sebastian M. Armasu; Australian Cancer Study; Australian Ovarian Cancer Study; François Bacot; Laura Baglietto; Elisa V. Bandera; Jill S. Barnholtz‐Sloan; Matthias W. Beckmann; Michael J. Birrer; Greg Bloom; Natalia Bogdanova; Louise A. Brinton; Angela Brooks‐Wilson; Robert Brown; Ralf Bützow; Qiuyin Cai; Ian Campbell; Jenny Chang‐Claude; Stephen J. Chanock; Georgia Chenevix‐Trench; Jin Q. Cheng; Mine S. Cicek; Gerhard A. Coetzee; Linda S. Cook; Fergus J. Couch; Daniel W. Cramer; Julie M. Cunningham; Agnieszka Dansonka‐Mieszkowska; Evelyn Despierre; Jennifer A. Doherty; Thilo Dörk; Andreas du Bois; Matthias Dürst; Douglas F. Easton; Diana Eccles; Robert P. Edwards; Arif B. Ekici; Peter A. Fasching; David Fenstermacher; James M. Flanagan; Montserrat García‐Closas; Aleksandra Gentry‐Maharaj; Graham G. Giles; Rosalind Glasspool; Jesús González Bosquet; Marc T. Goodman; Martin Gore; Bohdan Górski; Jacek Gronwald; Per Hall; Mari K. Halle; Philipp Harter; Florian Heitz; Peter Hillemanns; Maureen E. Hoatlin; Claus Høgdall; Estrid Høgdall; Satoyo Hosono; Anna Jakubowska; Allan Jensen; Heather Jim; Kimberly R. Kalli; Beth Y. Karlan; Stanley B. Kaye; Linda E. Kelemen; Lambertus A. Kiemeney; Fumitaka Kikkawa; Gottfried E. Konecny; Camilla Krakstad; Susanne K. Kjær; Jolanta Kupryjańczyk; Diether Lambrechts; Sandrina Lambrechts; Johnathan M. Lancaster; Nhu D. Le; Arto Leminen; Douglas A. Levine; Dong Liang; Boon Kiong Lim; Jie Lin; Jolanta Lissowska; Karen H. Lu; Jan Lubiński; Galina Lurie; Leon F.A.G. Massuger; Keitaro Matsuo; Valerie McGuire; John R. McLaughlin; Usha Menon; Francesmary Modugno; Kirsten B. Moysich; Toru Nakanishi; Steven A. Narod; Lotte Nedergaard; Roberta B. Ness; Heli Nevanlinna; Stefan Nickels; Houtan Noushmehr; Kunle Odunsi; Sara H. Olson; Irene Orlow; James Paul; Celeste Leigh Pearce; Tanja Pejović; Liisa M. Pelttari; Malcolm C. Pike; Elizabeth M. Poole; Paola Raska; Stefan P. Renner; Harvey A. Risch; Lorna Rodríguez-Rodríguez; Mary Anne Rossing; Anja Rudolph; Ingo B. Runnebaum; Iwona K. Rzepecka; Helga B. Salvesen; Ira Schwaab; Gianluca Severi; Viji Shridhar; Xiao‐Ou Shu; Yurii B. Shvetsov; Weiva Sieh; Honglin Song; Melissa C. Southey; Beata Śpiewankiewicz; Daniel O. Stram; Rebecca Sutphen; Soo‐Hwang Teo; Kathryn L. Terry; Daniel C. Tessier; Pamela J. Thompson; Shelley S. Tworoger; Anne M. van Altena; Ignace Vergote; Robert A. Vierkant; Daniel Vincent; Allison F. Vitonis; Shan Wang‐Gohrke; Rachel Palmieri Weber; Nicolas Wentzensen; Alice S. Whittemore; Elisabeth Wik; Lynne R. Wilkens; Boris Winterhoff; Yin Ling Woo; Anna H. Wu; Yong‐Bing Xiang; Hannah Yang; Wei Zheng; Argyrios Ziogas; Famida Zulkifli; Catherine M. Phelan; Edwin S. Iversen; Joellen M. Schildkraut; Andrew Berchuck; Brooke L. Fridley; Ellen L. Goode; Paul D.P. Pharoah; Álvaro N.A. Monteiro; Thomas A. Sellers; Simon A. Gayther

doi:10.1038/ncomms2613

Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31

Jennifer Permuth‐Wey(Moffitt Cancer Center), Kate Lawrenson(University of Southern California), Howard C. Shen(University of Southern California), Aneliya Velkova(Moffitt Cancer Center), Jonathan P. Tyrer(University of Cambridge), Zhihua Chen(Moffitt Cancer Center), Hui‐Yi Lin(Moffitt Cancer Center), Y. Ann Chen(Moffitt Cancer Center), Ya-Yu Tsai(Moffitt Cancer Center), Xiaotao Qu(Moffitt Cancer Center), Susan J. Ramus(University of Southern California), Rod Karevan(University of Southern California), Janet Lee(University of Southern California), Nathan Lee(University of Southern California), Melissa C. Larson(Mayo Clinic in Florida), Katja K.H. Aben(Radboud University Nijmegen), Hoda Anton‐Culver(University of California, Irvine), Natalia Antonenkova, Antonis C. Antoniou(University of Cambridge), Sebastian M. Armasu(Mayo Clinic in Florida), Australian Cancer Study(McGill University and Génome Québec Innovation Centre), Australian Ovarian Cancer Study(The University of Melbourne), François Bacot(Rutgers Cancer Institute), Laura Baglietto(University School), Elisa V. Bandera(Universitätsklinikum Erlangen), Jill S. Barnholtz‐Sloan(Massachusetts General Hospital), Matthias W. Beckmann(Moffitt Cancer Center), Michael J. Birrer(Medizinische Hochschule Hannover), Greg Bloom(National Cancer Institute), Natalia Bogdanova(BC Cancer Agency), Louise A. Brinton(Imperial College London), Angela Brooks‐Wilson(University of Helsinki), Robert Brown(Vanderbilt University), Ralf Bützow(The University of Melbourne), Qiuyin Cai(German Cancer Research Center), Ian Campbell(National Cancer Institute), Jenny Chang‐Claude(QIMR Berghofer Medical Research Institute), Stephen J. Chanock(Moffitt Cancer Center), Georgia Chenevix‐Trench(Mayo Clinic), Jin Q. Cheng(University of Southern California), Mine S. Cicek(University of New Mexico), Gerhard A. Coetzee(Mayo Clinic), Linda S. Cook(Brigham and Women's Hospital), Fergus J. Couch(Mayo Clinic), Daniel W. Cramer(The Maria Sklodowska-Curie National Research Institute of Oncology), Julie M. Cunningham(KU Leuven), Agnieszka Dansonka‐Mieszkowska(Dartmouth College), Evelyn Despierre(Medizinische Hochschule Hannover), Jennifer A. Doherty(Helios Dr. Horst Schmidt Kliniken Wiesbaden), Thilo Dörk(Jena University Hospital), Andreas du Bois(University of Cambridge), Matthias Dürst(University Hospital Southampton NHS Foundation Trust), Douglas F. Easton(Magee-Womens Hospital), Diana Eccles(Friedrich-Alexander-Universität Erlangen-Nürnberg), Robert P. Edwards(Universitätsklinikum Erlangen), Arif B. Ekici(Moffitt Cancer Center), Peter A. Fasching(Imperial College London), David Fenstermacher(Institute of Cancer Research), James M. Flanagan(Breast Cancer Now), Montserrat García‐Closas(The University of Melbourne), Aleksandra Gentry‐Maharaj(Beatson West of Scotland Cancer Centre), Graham G. Giles(Moffitt Cancer Center), Rosalind Glasspool(Cedars-Sinai Medical Center), Jesús González Bosquet(Royal Marsden Hospital), Marc T. Goodman(International Hereditary Cancer Center), Martin Gore(International Hereditary Cancer Center), Bohdan Górski(Karolinska Institutet), Jacek Gronwald(Haukeland University Hospital), Per Hall(Helios Dr. Horst Schmidt Kliniken Wiesbaden), Mari K. Halle(Helios Dr. Horst Schmidt Kliniken Wiesbaden), Philipp Harter(Medizinische Hochschule Hannover), Florian Heitz(Oregon Health & Science University), Peter Hillemanns(Rigshospitalet), Maureen E. Hoatlin(University of Copenhagen), Claus Høgdall(Aichi Cancer Center), Estrid Høgdall(International Hereditary Cancer Center), Satoyo Hosono(Danish Cancer Society), Anna Jakubowska(Moffitt Cancer Center), Allan Jensen(Mayo Clinic), Heather Jim(Cedars-Sinai Medical Center), Kimberly R. Kalli(Institute of Cancer Research), Beth Y. Karlan(Alberta Health Services), Stanley B. Kaye(Radboud University Nijmegen), Linda E. Kelemen(Nagoya University), Lambertus A. Kiemeney(University of California, Los Angeles), Fumitaka Kikkawa(Haukeland University Hospital), Gottfried E. Konecny(Rigshospitalet), Camilla Krakstad(The Maria Sklodowska-Curie National Research Institute of Oncology), Susanne K. Kjær(KU Leuven), Jolanta Kupryjańczyk(KU Leuven), Diether Lambrechts(Moffitt Cancer Center), Sandrina Lambrechts(BC Cancer Agency), Johnathan M. Lancaster(University of Helsinki), Nhu D. Le(Memorial Sloan Kettering Cancer Center), Arto Leminen(Texas Southern University), Douglas A. Levine(University of Malaya), Dong Liang(The University of Texas MD Anderson Cancer Center), Boon Kiong Lim(The Maria Sklodowska-Curie National Research Institute of Oncology), Jie Lin(The University of Texas MD Anderson Cancer Center), Jolanta Lissowska(International Hereditary Cancer Center), Karen H. Lu(University of Hawaiʻi at Mānoa), Jan Lubiński(Radboud University Nijmegen), Galina Lurie(Aichi Cancer Center), Leon F.A.G. Massuger(Stanford University), Keitaro Matsuo(Mount Sinai Hospital), Valerie McGuire(Breast Cancer Now), John R. McLaughlin(University of Pittsburgh), Usha Menon(Roswell Park Comprehensive Cancer Center), Francesmary Modugno(Aichi Cancer Center), Kirsten B. Moysich(University of Toronto), Toru Nakanishi(University of Copenhagen), Steven A. Narod(The University of Texas Health Science Center at Houston), Lotte Nedergaard(Helsinki University Hospital), Roberta B. Ness(German Cancer Research Center), Heli Nevanlinna(University of Southern California), Stefan Nickels(Roswell Park Comprehensive Cancer Center), Houtan Noushmehr(Memorial Sloan Kettering Cancer Center), Kunle Odunsi(Memorial Sloan Kettering Cancer Center), Sara H. Olson(Beatson West of Scotland Cancer Centre), Irene Orlow(University of Southern California), James Paul(Oregon Health & Science University), Celeste Leigh Pearce(Helsinki University Hospital), Tanja Pejović(University of Southern California), Liisa M. Pelttari(Brigham and Women's Hospital), Malcolm C. Pike(University School), Elizabeth M. Poole(Universitätsklinikum Erlangen), Paola Raska(Yale University), Stefan P. Renner(Rutgers Cancer Institute), Harvey A. Risch(University of Washington), Lorna Rodríguez-Rodríguez(German Cancer Research Center), Mary Anne Rossing(Jena University Hospital), Anja Rudolph(The Maria Sklodowska-Curie National Research Institute of Oncology), Ingo B. Runnebaum(Haukeland University Hospital), Iwona K. Rzepecka, Helga B. Salvesen(The University of Melbourne), Ira Schwaab(Mayo Clinic), Gianluca Severi(Vanderbilt University), Viji Shridhar(University of Hawaiʻi at Mānoa), Xiao‐Ou Shu(Stanford University), Yurii B. Shvetsov(University of Cambridge), Weiva Sieh(The University of Melbourne), Honglin Song(The Maria Sklodowska-Curie National Research Institute of Oncology), Melissa C. Southey(University of Southern California), Beata Śpiewankiewicz(University of South Florida), Daniel O. Stram(University of Malaya), Rebecca Sutphen(Brigham and Women's Hospital), Soo‐Hwang Teo(McGill University and Génome Québec Innovation Centre), Kathryn L. Terry(Cedars-Sinai Medical Center), Daniel C. Tessier(Brigham and Women's Hospital), Pamela J. Thompson(Radboud University Nijmegen), Shelley S. Tworoger(KU Leuven), Anne M. van Altena(Mayo Clinic in Florida), Ignace Vergote(McGill University and Génome Québec Innovation Centre), Robert A. Vierkant(Brigham and Women's Hospital), Daniel Vincent(Universität Ulm), Allison F. Vitonis(Duke Medical Center), Shan Wang‐Gohrke(National Cancer Institute), Rachel Palmieri Weber(Stanford University), Nicolas Wentzensen(Haukeland University Hospital), Alice S. Whittemore(University of Hawaiʻi at Mānoa), Elisabeth Wik(Mayo Clinic), Lynne R. Wilkens(University of Malaya), Boris Winterhoff(University of Southern California), Yin Ling Woo(Shanghai Cancer Institute), Anna H. Wu(National Cancer Institute), Yong‐Bing Xiang(Vanderbilt University), Hannah Yang(University of California, Irvine), Wei Zheng(University of Malaya), Argyrios Ziogas(Moffitt Cancer Center), Famida Zulkifli(Duke University), Catherine M. Phelan(Duke Medical Center), Edwin S. Iversen(Duke Medical Center), Joellen M. Schildkraut(University of Kansas Medical Center), Andrew Berchuck(Mayo Clinic), Brooke L. Fridley(University of Cambridge), Ellen L. Goode(Moffitt Cancer Center), Paul D.P. Pharoah(Moffitt Cancer Center), Álvaro N.A. Monteiro(University of Southern California), Thomas A. Sellers, Simon A. Gayther

Nature Communications

March 27, 2013

10.1038/ncomms2613

Cited by 109Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis